The paper reports a study which was carried out to assess immunological function by assaying IL2 in cancer-operated patients treated with thymostimulin. The results of the study show that, used in normally fed, immunodepressed patients, this immunomodulator is able to normalise levels of lymphocyte subpopulations and to bring serum concentrations of IL2-RS to the levels of normoergic patients.
|Translated title of the contribution||Immunological variations following thymic stimulation paying special attention to IL2-RS in cancer-operated patients|
|Number of pages||4|
|Publication status||Published - 1991|
ASJC Scopus subject areas